A glaucoma diagnosis can bring many questions and concerns about your eye health and future. While it may feel overwhelming at first, taking the right steps can help you navigate this new reality with confidence. Learning about your condition, seeking appropriate care, and making informed decisions will be key to managing it effectively. By taking a proactive approach,
TGF News
TGF Founder Dr. Robert Ritch Steps Down from The Glaucoma Foundation
Dr. Robert Ritch, the founder of The Glaucoma Foundation (TGF) and its Medical Director and Co-Chair of its Scientific Advisory Board, is stepping down from these roles as of March 1st after 40 years of exceptional service. “We are most grateful for Dr. Ritch’s outstanding and singular contributions over the years,” said Dr. Gregory K. Harmon, TGF’s Board Chairman. “As
Creating a Supportive Workplace: Strategies for Including Employees with Disabilities

Creating a workplace that values diversity and inclusivity is not only ethically sound but also strategically beneficial. By focusing on the integration and support of employees with disabilities, organizations can tap into a broader range of talents and perspectives. This approach requires thoughtful implementation of supportive structures and incentives that cater to the unique needs of these employees.
Doctor, I Have a Question. What Are Some Recent Advances in the Treatment of Glaucoma?

Question answered by: While there is still no cure for glaucoma, the past year has seen advances in several aspects of the disease – for example, sustained-release glaucoma medications that can improve compliance and treatment efficiency, devices that help clinicians treat glaucoma, and encouraging research results. It is estimated that almost half of glaucoma patients do not take their eyedrop
Message From The President

Dear Readers, I extend our best wishes for a healthy and good new year. Here at the Foundation, we are ringing in 2025 with a special project to highlight the observance of Glaucoma Awareness Month. Each day this month, TGF is posting a new message on social media to shine a spotlight on patients and others who are tackling this
Taking Lifestyle into Account

At the June TGF Symposium, a presentation on the genetics of glaucoma was followed by a talk by Pradeep Ramulu, MD, PhD on “Taking Lifestyle into Account.” Dr. Ramulu is chief of glaucoma at the Wilmer Eye Institute at Johns Hopkins in Baltimore. He asked: “If glaucoma is the third most heritable disease, is there reason to focus
Doctor, I Have a Question. My eye doctor recently took images of my eye using different devices. What do they show?

Question answered by: Clinicians have a range of tools to help diagnose glaucoma and measure its progression. Imaging devices are an important part of the toolbox. You probably had an OCT (optical coherence tomography) test, which allows us to measure the thickness of the different layers of the retina and optic nerve. Just as a sonogram uses sound waves to
The State of Genetic Testing for Glaucoma

When Dr. Janey Wiggs gave a presentation on Genetics and Glaucoma at last summer’s TGF Symposium, she spoke about genetics as a tool we should be using hand in hand with all our other clinical tools. “Glaucoma is actually one of the most heritable of all human conditions,” she explained. “The genetics are so strong for the disease that
How to Support Hard of Hearing Loved Ones with Glaucoma

According to studies, although different factors may cause sensorineural hearing loss and glaucoma, they both share a pathophysiology of neurodegeneration. This means that although the occurrence of both diseases in a single individual is not common, it may happen more often than what was previously thought. As it is, about three million Americans have glaucoma, while 30 million have
Doctor, I Have a Question. I’ve been hearing more about the need for preservative-free glaucoma eye drops. Why is this need increasing?

Question answered by: In the past decade, awareness has gradually increased regarding the high prevalence of ocular surface disease among glaucoma patients, particularly dry eye disease, which is linked to the preservatives in glaucoma drops. Currently, approximately 80% of glaucoma eye drops on the US market contain preservatives. The most commonly used preservative is benzalkonium chloride (BAK), found in concentrations